Global Atopic Dermatitis Drugs Market Report 2021-2027: Corticosteroids Segment to Account for $3.2 Billion of the Total $5.1 Billion - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 7, 2021--
The “Atopic Dermatitis Drugs - Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Global Atopic Dermatitis Drugs Market to Reach $7.4 Billion by 2027
Amid the COVID-19 crisis, the global market for Atopic Dermatitis Drugs estimated at US$5.1 Billion in the year 2020, is projected to reach a revised size of US$7.4 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027.
Corticosteroids, one of the segments analyzed in the report, is projected to record a 5.7% CAGR and reach US$3.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Calcineurin Inhibitors segment is readjusted to a revised 5.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 8.2% CAGR
The Atopic Dermatitis Drugs market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.
Biologics Segment to Record 6.8% CAGR
In the global Biologics segment, USA, Canada, Japan, China and Europe will drive the 6.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$312.4 Million in the year 2020 will reach a projected size of US$478.6 Million by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$997.2 Million by the year 2027, while Latin America will expand at a 8.1% CAGR through the analysis period.
Select Competitors (Total 43 Featured):
- Allergan Plc
- Anacor Pharmaceutical Inc.
- Astellas Pharma, Inc.
- Bayer AG
- Bristol-Myers Squibb Company
- Encore Dermatology
- Leo Pharma
- Meda Pharmaceuticals
- Novartis International AG
- Regeneron Pharmaceuticals, Inc.
- Valent Pharmaceutical Inc.
Key Topics Covered:
II. EXECUTIVE SUMMARY
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
III. MARKET ANALYSIS
- Total Companies Profiled: 43
For more information about this report visit https://www.researchandmarkets.com/r/ctzrta
View source version on businesswire.com:https://www.businesswire.com/news/home/20210407005669/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 04/07/2021 09:57 AM/DISC: 04/07/2021 09:57 AM